Africa’s First CoC Registry Goes Live for SA’s 20 September Trade Deadline 
Santamarina + Steta Strengthens Its Tax Practice with the Addition of Luis Curiel Pina and Francisco Carbajal Dominguez 
Berry AI and Culver’s Announce Brand-Wide Vision AI Deployment Across 1,000+ Restaurants 
Sensiba Names Monic Ramirez as Managing Partner Amid Firm-Wide Transformation Accelus Announces Addition of TiHawk9™ Titanium-Bonded Multidirectional Implant to its FlareHawk® Family of Expandable Interbody Fusion Cages
TiHawk blends features of PEEK with titanium for a modulus more similar to bone that…
UPDATE — Axiom Presents “Rare Disease Studies – Using technology to expand the opportunities of enrollment” at Clinical Trials in Rare Diseases Conference 2021
TORONTO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), a premier provider of…
T2 Biosystems to Unveil New Data at September Conferences
Leading rapid diagnostics company to share new research at industry conferences throughout Sepsis Awareness Month LEXINGTON,…
Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics
Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and…
Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointments of John Rossi, Ph.D. and Nagy Habib, Ch.M., F.R.C.S. to the Scientific Advisory Board
Dr. Rossi is a world leader in the development of RNA interference, the Lidow Family…
Skye Bioscience Announces Special Virtual Investor Presentation
Skye Bioscience Investor Hour Please join us for a special investor presentation. SAN DIEGO, CA,…
Nkarta to Participate at Upcoming Investor Conference
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a…
Published Study Shows Healthy Extracts Breakthrough Nutraceutical Formulation, ACTIVATE, Naturally Enhances Key Brain Activity by 46%
UBN ACTIVATE™ UBN ACTIVATE™ is clinically proven to enhance brain function, improve cognition, memory, focus,…
Acasti Pharma to Present at the Oppenheimer Fall Healthcare Summit on September 21ˢᵗ
LAVAL, Québec, Sept. 14, 2021 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”)…
SELLAS Life Sciences to Present at the 2021 Cantor Virtual Global Healthcare Conference on September 28th
NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)…
Vallon Pharmaceuticals Announces Formation of Scientific Advisory Board
– Inaugural appointments include globally renowned leaders and experts on attention-deficit/hyperactivity disorder (ADHD) and stimulant…
Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment resistant depression
NEW YORK and BERLIN, Sept. 14, 2021 (GLOBE NEWSWIRE) — Perception Neuroscience (Perception), an atai…
Pyxis Oncology Appoints Jay M. Feingold, M.D., Ph.D., as Chief Medical Officer
Industry veteran strengthens Pyxis team with expertise in clinical development, medical affairs and antibody-drug conjugates…
Medicenna Doses First Patient in MDNA11 Phase 1/2 ABILITY Study
— Trial designed to assess safety, pharmacokinetics (PK), pharmacodynamics (PD), and anti-tumor activity of MDNA11…
Werewolf Therapeutics to Present at Upcoming Next-Gen Cytokine Therapeutics Summit
CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (Nasdaq: HOWL), an innovative…
Kronos Bio Appoints Marni Kottle as Senior Vice President of Corporate Communications and Investor Relations
SAN MATEO, Calif. and CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) — Kronos Bio, Inc….
Aprea Therapeutics to Present Data from Phase 1/2 Trial of Eprenetapopt in Advanced Solid Tumors at ESMO Congress 2021
BOSTON, Sept. 14, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused…
Immunophotonics Announces Issuance of U.S. Patent Covering Lead Drug Candidate
ST. LOUIS and BERN, Switzerland, Sept. 14, 2021 (GLOBE NEWSWIRE) — Immunophotonics, Inc., a clinical-stage…
Nuvectis Pharma In-Licenses Exclusive Worldwide Rights to a Novel SRC/YES1 Inhibitor (NXP900) from the University of Edinburgh, Scotland
•NXP900 is a SRC/YES1 Kinase Inhibitor with a Novel and Differentiated Mechanism of Action. FORT…
Beyond Air® to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
GARDEN CITY, N.Y., Sept. 14, 2021 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a…